News

head uk2

Scientific news - Chitin and Chitosan

HMC 0309 185In this rubric we present you scientific news from the world of chitin and chitosan. Monthly you can find recent publications. We hope to arouse your interest in this biopolymer or to help you out. If you have any comments or if you do chitin or chitosan research and you want to publish your article on this page, This email address is being protected from spambots. You need JavaScript enabled to view it.

Have fun browsing on our pages!

rss

Chitosan nanoparticles - potential drug delivery systems for COVID-19 drugs

Published on

Tags: nanoparticles, Corona

Chitosan nanoparticles can deliver drugs to their specific target site and release them over a long period. In current corona crisis, chitosan nanoparticles could be one way to release potential COVID-19 drugs specifically in the lungs of affected patients. A potential drug delivery system for the treatment of SARS-CoV-2 infected persons is Novochizol™, consisting of chitosan-based nanoparticles.

Chitosan against Corona? Substituted chitosan as effective inhibitor of SARS-CoV-2 and MERS-CoV

Published on

Tags: chitosan, vaccine, Corona, MERS-CoV , SARS-CoV-2

The new corona virus SARS-CoV-2 has spread globally, originating from China since the beginning of the year. The pathogen causes the lung disease Covid-19 and has been classified as a pandemic since March 11, 2020. Researchers around the world are working on the development of effective vaccinations and drugs. A current study examined the antiviral effectiveness of HTCC (N- (2-hydroxypropyl) -3-trimethylammonium chitosan chloride) in vitro and ex vivo against the new coronavirus SARS-CoV-2 and MERS-CoV.

Chitosan as adjuvant for vaccines

Published on

Tags: drug delivery, nanoparticles, adjuvant, Vaccines, Chitosan HCl

Adjuvants in vaccines are potent enhancers, which ensure that even small amounts of pathogens induce a permanent immune response. They are particularly necessary for inactivated vaccines and vaccines with antigen subunits. Several studies investigated chitosan as an adjuvant or antigen delivery system in various formulations (gels, aqueous dispersion, micro- and nanoparticles).

How to read our certificate of analysis?

Published on

Tags: CoA, Certifiate of Analysis, Quality control

A certificate of analysis (CoA) is a document that confirms that the product meets its product specifications and is issued for each batch of product by quality assurance. The certificate of analysis contains the specifications for the specified parameters and the actual results of analysis of the parameters for this product batch. The certificate of analysis is sent together with the product to our customers. In the following we explain in detail how to read a certificate of analysis of our chitosan products and how can you cite it in your scientific articles.

Congress and fairs

Meet us in person 2022:

  • EUCHIS, 2022
  • CPHI 2022
  • Medica 2022
  • Asia Pacific Chitin and Chitosan Symposium, 2022, South Korea

To arrange an appointment please contact Katja Richter via sales(at)medical-chitosan.com

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • sales@medical-chitosan.com

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.